Braskem Gains Ground as Novonor Moves Forward with Stake Sale Negotiations
Braskem's Stake Sale: Braskem's shares rose by 5.5% after Novonor announced an agreement to sell a controlling stake in the company to private equity firm IG4 Capital, which will share control with Petrobras.
Novonor's Retained Stake: Novonor will keep a 4% stake in Braskem, which was previously collateral for unpaid loans, and has a 60-day period to finalize the transaction.
Potential Benefits of New Ownership: The change in controlling shareholders could improve Braskem's outlook, as the company faces challenges with low petrochemical margins and liabilities from environmental damage in Maceio.
Market Context: The deal comes amid ongoing financial struggles for Braskem, highlighting the need for a strategic shift to enhance its operational stability and market position.
Get Free Real-Time Notifications for Any Stock
Analyst Views on BAK
About BAK
About the author

Qube Research Discloses 1% Stake in Bakkavor Group PLC
- Stake Disclosure: Qube Research & Technologies Limited disclosed a holding of 5,899,795 cash-settled derivatives in Bakkavor Group PLC, representing a 1% interest, indicating its investment intentions in the company.
- Trading Details: In recent transactions, Qube executed multiple equity swaps of 2p ordinary shares, reducing long positions at prices ranging from 229 to 233.50 pence, reflecting its strategy to navigate market volatility.
- Regulatory Compliance: This disclosure adheres to Rule 8.3 of the Takeover Code, ensuring transparency and compliance, which underscores Qube's commitment to regulatory standards.
- Market Impact: Qube's stake disclosure may influence Bakkavor's market performance, prompting investors to monitor subsequent stock price fluctuations and market reactions.

Qube Research Discloses 1% Stake in Bakkavor Group PLC
- Stake Disclosure: Qube Research & Technologies Limited disclosed a holding of 5,836,498 cash-settled derivatives in Bakkavor Group PLC, representing a 1% stake, indicating its investment interest in the company.
- Trading Details: In recent transactions, Qube increased its long positions through equity swaps at prices ranging from 230.50 to 233.50 pence per share, reflecting its positive outlook on Bakkavor's future performance.
- Regulatory Compliance: This disclosure adheres to Rule 8.3 of the Takeover Code, ensuring market transparency and demonstrating Qube's commitment to compliance and information disclosure.
- Market Impact: Qube's stake disclosure may influence Bakkavor's market performance, prompting investors to monitor subsequent stock price fluctuations and market reactions.









